03.11.2015 • NewsDede WillamsElaine BurridgeDuPont

DuPont Reorganizes, Completes Neoprene Sale

DuPont’s interim CEO Edward Breen, who took the helm following the resignation of long-time CEO Ellen Kullman in mid-October, has lost no time in streamlining the chemical giant’s activities.

The changes, which will become effective on Jan. 1, 2016, will create greater efficiency and enhanced capabilities while improving economies of scale and leading to more effective deployment of capital, the US group said. The number of reporting segments will be left unchanged at six.

Plans call for the Packaging & Industrial Polymers business unit to be combined with the Performance Polymers unit into a Performance Materials reporting segment, to be headed by Patrick E. Lindner, who currently heads Performance Polymers. Products include polyamide and polyester resins.

The Protection Technologies unit, which encompasses the high-tech Aramid fiber among other products, will be combined with Building Innovations into a single business unit that will be called Protection and headed by Rose Lee. It will be part of the existing Safety & Protection segment, which also includes Sustainable Solutions.

DuPont meanwhile has completed the sale of its chloroprene rubber business at La Place, Louisiana, USA, to Japan’s Denka Performance Elastomer. The deal, which was announced in December last year, was finalized on Oct. 31.

Denka said it successfully started up the chloroprene rubber plant at the site on Nov. 1. The US plant is the second chloroprene rubber facility for Denka which also operates a plant in Omi, Niigata prefecture.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.